Results 111 to 120 of about 180,777 (427)
Pulmonary Vein Isolation for Atrial Fibrillation
The efficacy of pulmonary vein isolation (PVI) as a treatment for drug-refractory atrial fibrillation (AF) has been established through more than 15 years of clinical studies, which have shown consistent, reproducible results worldwide.
Francis E. Marchlinski+1 more
openaire +4 more sources
Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models
This review discusses kidney diseases with a focus on kidney fibrosis and the models currently used. It highlights the limitations of animal and 2D in vitro models in replicating human kidney anatomy and physiology. Consequently, there is a significant need for humanized 3D in vitro models, such as 3D cell aggregates, membranes and hydrogels, on‐chip ...
Gabriele Addario+2 more
wiley +1 more source
We report the case of a 56-year-old female who presented with symptomatic paroxysmal atrial fibrillation. Anamnestic heparin-induced thrombocytopenia (HIT) type II was suspected, and a rapid diagnostic test showed antibodies against platelet factor 4 ...
Barbara Bellmann, MD+2 more
doaj +1 more source
Rod‐shaped particles outperform spherical particles of the same volume in preventing neutrophil infiltration to inflamed areas, both in vitro and in vivo. This therapeutic effectiveness is attributed to better cell targeting and decreased cell motility, resulting from the geometry‐driven phagocytosis and inhibited actin polymerization.
M. Valentina Guevara+7 more
wiley +1 more source
Three cases of vasospastic angina following catheter ablation of atrial fibrillation
Pulmonary vein isolation is an effective treatment for patients with atrial fibrillation (AF).Although vasospastic angina (VSA) is not a common complication after ablation of AF, we report 3 cases of VSA following ablation of persistent AF.
Yoshihiko Kagawa+4 more
doaj +1 more source
Totally Thoracoscopic Pulmonary Vein Isolation [PDF]
Since the introduction of thoracoscopic ablation for atrial fibrillation (AF), the field of minimally invasive AF treatment has evolved toward an established treatment option for AF, with an overall 2-year antiarrhythmic drug free success rate of 77%.
Al-Jazairi, Meelad I H+4 more
openaire +2 more sources
Aims Atrial fibrillation (AF) in patients suffering from heart failure with preserved ejection fraction (HFpEF) is associated with increased symptoms and higher morbidity and mortality.
M. Rattka+10 more
semanticscholar +1 more source
Designing for Degradation: Transient Devices Enabled by (Nano)Cellulose
Recent progress in transient devices enabled by (nano)cellulosic materials is reviewed. Transiency mechanisms, advantages of nanocelluloses, and a suite of applications are discussed. A circular thinking approach coupled with life cycle assessment is applied to critically revisit the potential, advantages, and challenges of nanocellulose‐enabled ...
Lucas J. Andrew+2 more
wiley +1 more source
Detecting and monitoring arrhythmia recurrence following catheter ablation of atrial fibrillation. [PDF]
Atrial fibrillation (AF) is the most common arrhythmia prompting clinical presentation, is associated with significant morbidity and mortality. The incidence and prevalence of this arrhythmia is expected to grow significantly in the coming decades.
Ajijola, Olujimi A+2 more
core +2 more sources
Seeking an Optimal Approach for Computer-Aided Pulmonary Embolism Detection [PDF]
Pulmonary embolism (PE) represents a thrombus ("blood clot"), usually originating from a lower extremity vein, that travels to the blood vessels in the lung, causing vascular obstruction and in some patients, death. This disorder is commonly diagnosed using CT pulmonary angiography (CTPA).
arxiv